Evidence map›Paper›PMID 31502041›Full record

ArticleJournal of neuro-oncology2019

Correction to: Phase II study of weekly carboplatin in pretreated adult malignant gliomas.

Veronica Villani, Andrea Pace, Antonello Vidiri, Antonio Tanzilli, Francesca Sperati, Irene Terrenato, Mariantonia Carosi, Beatrice Casini, Giulio Metro, Marta Maschio and 3 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Veronica VillaniNeuro-Oncology Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Andrea PaceNeuro-Oncology Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Antonello VidiriService of Neuroradiology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Antonio TanzilliNeuro-Oncology Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Francesca SperatiBiostatistic Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Irene TerrenatoBiostatistic Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Mariantonia CarosiDivision of Neuropathology, IRCCS - Regina Elena' National Cancer Institute, Rome, Italy.
Beatrice CasiniDivision of Neuropathology, IRCCS - Regina Elena' National Cancer Institute, Rome, Italy.
Giulio MetroOspedale Santa Maria Della Misericordia Azienda Ospedaliera Di Perugia, Perugia, Italy.
Marta MaschioNeuro-Oncology Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Tatiana KoudriavtsevaNeuro-Oncology Unit, IRCCS - Regina Elena National Cancer Institute, Rome, Italy.
Francesco CognettiUniversità La Sapienza Roma, Rome, Italy.
Alessandra FabiDivision of Medical Oncology, IRCCS - Regina Elena National Cancer Institute, Rome, Italy. alessandra.fabi@ifo.gov.it.ORCID http://orcid.org/0000-0002-6320-2609

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the original article, the names of authors Mariantonia Carosi and Tatiana Koudriavtseva were incorrectly captured, and author Francesco Cognetti's affiliation was incorrect. The information is correctly shown here.

Identifiers

PMID31502041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.